Close Menu

University of British Columbia

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Genome British Columbia and Genome Canada today announced nearly C$4.3million (US$4.3 million) in funding for the development of genomic diagnostics aimed at forest disease.

People in the News: Sep 7, 2011

Premium

The National Institutes of Health has appointed Mark Guyer to deputy director of the National Human Genome Research Institute and James Mullikin to director of the NIH Intramural Sequencing Center.

In a paper published this week in PNAS, a University of British Columbia team led by Fluidigm SAB member Carl Hansen described a fully integrated microfluidic device for performing reverse transcription quantitative PCR and measuring single-cell gene expression in hundreds of cells in parallel.

The technology could improve the utility of digital PCR in diagnostic applications, and help drive the technique's adoption as a low-cost alternative to quantitative real-time PCR for applications such as copy number variation, rare allele detection, and single-cell gene expression analysis.

In the hopes of understanding brain developmental disorders, UBC will use Genome BC funding to work with Riken to identify genes involved in cerebellum development.

Under the terms of the research alliance, which was forged in 2009, Alnylam has the exclusive rights to all new inventions in the RNAi field, as well as rights to sublicense any resulting intellectual property to Alnylam's current and future partners.

Pages

At the Lancet, more than two dozen public health researchers condemn the conspiracy theories that have emerged surrounding the source of the COVID-19 outbreak.

The Washington Post reports that Philip Leder, who helped uncover how DNA codes for proteins and studied the role of genes in cancer, has died.

Researchers from Trinity College Dublin and the University of Pittsburgh look into how often de novo genes arise and how important they may be.

In Nucleic Acids Research this week: pipeline for genotyping Alu retrotransposon mobile element insertions, previously undocumented non-coding RNAs, and more.